Sensex and Nifty Slip Sharply as Global Weakness Mounts, but Pharma Stocks Stage a Rally

Sensex and Nifty Slip Sharply as Global Weakness Mounts, but Pharma Stocks Stage a Rally​

Indian equity indices recorded sharp declines on June 22 as uncertainty surrounding US-Iran peace talks weighed heavily on market sentiment globally. The benchmark indices closed in red, with selling pressure intensifying through the second half of the trading session.

At the close, the Sensex finished at 76,200.68, shedding 893.39 points or 1.16 percent. Nifty was also significantly pulled down, settling at 23,824.10, marking a decline of 278.80 points or 1.16 percent.

Market Performance and Sectoral Resilience​

The market saw concentrated selling across several key sectors, though pharma and healthcare stocks provided crucial support to the broader indices. While IT, Metal, Telecom, PSU Bank, and Realty all closed in the red, these struggling sectors registered losses ranging from one to three percent.

Broader markets also reflected this trend, with both the smallcap index dipping by 0.5 percent and the midcap index shedding 1 percent. This performance occurred amid a backdrop of weak global market conditions, dampening overall investor sentiment. The Indian rupee, meanwhile, finished 5 paise lower at 94.73 against the US dollar.

Individual Stock Movers and Corporate News​

The trading session saw dramatic action across individual stocks. Infosys, TCS, Wipro, Adani Enterprises, and JSW Steel were among the biggest Nifty losers. Conversely, Cipla, Dr Reddy's Labs, Power Grid Corp, Axis Bank, and Sun Pharma listed among the gainers, underlining the resilience in the healthcare segment.

In specific stock news, Syrma SGS Technology climbed nearly 3 percent after securing a manufacturing agreement with Japan-based Kaga Electronics to establish an EMS facility in India. Meesho shares surged 8 percent following Citi initiating a 'buy' rating with a target price of Rs 210. Vedanta, however, saw a sharp decline, plunging 7.8 percent in block deals.

Expert Analysis and Short-Term Outlook​

Analysts point to the current weakness as a healthy downward correction within an existing uptrend, given the stellar rally witnessed earlier this month. Nagaraj Shetti of HDFC Securities noted that while the short-term trend appears weak, the near-term uptrend remains intact.

Ajit Mishra from Religare Broking emphasized that selling pressure was largely driven by Asian markets and weaknesses in metal and IT stocks. He advised that a stock-specific approach is warranted given the mixed market setup and increased volatility indicators.

Crucial Technical Support Levels​

Technically, the index faces critical support zones following the sharp selloff. The Nifty is approaching a key support range between 23,750 and 23,650, which coincides with both the 20-day EMA and a prior gap area.

Sustaining above this crucial zone will be essential for the gradual uptrend to resume. The immediate resistance level remains set at the 24,000 mark, while the long-term view suggests that a bounce from the 23,600 support could occur in the short term.